Mark P. Burgoon

1.5k total citations
26 papers, 1.2k citations indexed

About

Mark P. Burgoon is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Epidemiology. According to data from OpenAlex, Mark P. Burgoon has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Immunology and 9 papers in Epidemiology. Recurrent topics in Mark P. Burgoon's work include Monoclonal and Polyclonal Antibodies Research (20 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (9 papers). Mark P. Burgoon is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (20 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (9 papers). Mark P. Burgoon collaborates with scholars based in United States, Austria and Netherlands. Mark P. Burgoon's co-authors include Gregory P. Owens, Donald H. Gilden, Alanna Ritchie, Jeffrey L. Bennett, R. Anthony Williamson, John R. Corboy, Xiaoli Yu, Don Gilden, Mary Devlin and Andrew Shearer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Annals of Neurology.

In The Last Decade

Mark P. Burgoon

26 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark P. Burgoon United States 17 732 662 321 272 168 26 1.2k
Alanna Ritchie United States 20 900 1.2× 667 1.0× 230 0.7× 477 1.8× 209 1.2× 30 1.4k
H P Ekre Sweden 11 335 0.5× 650 1.0× 122 0.4× 224 0.8× 139 0.8× 13 1.2k
Ying C. Q. Zang United States 26 653 0.9× 937 1.4× 115 0.4× 119 0.4× 345 2.1× 35 1.6k
Chi Chao Chan United States 22 214 0.3× 196 0.3× 262 0.8× 278 1.0× 336 2.0× 38 1.6k
Claire H. Sweenie United Kingdom 8 272 0.4× 1.5k 2.2× 143 0.4× 51 0.2× 192 1.1× 9 1.8k
Purnima Sundar United States 14 247 0.3× 668 1.0× 471 1.5× 108 0.4× 221 1.3× 15 1.2k
M Flerlage United States 9 279 0.4× 777 1.2× 174 0.5× 36 0.1× 114 0.7× 9 975
Y. K. Chou United States 13 195 0.3× 759 1.1× 212 0.7× 38 0.1× 103 0.6× 18 996
William Siders United States 15 248 0.3× 472 0.7× 86 0.3× 77 0.3× 266 1.6× 26 875
Rachael Bashford-Rogers United Kingdom 19 113 0.2× 540 0.8× 169 0.5× 95 0.3× 235 1.4× 37 1.1k

Countries citing papers authored by Mark P. Burgoon

Since Specialization
Citations

This map shows the geographic impact of Mark P. Burgoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Burgoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Burgoon more than expected).

Fields of papers citing papers by Mark P. Burgoon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark P. Burgoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Burgoon. The network helps show where Mark P. Burgoon may publish in the future.

Co-authorship network of co-authors of Mark P. Burgoon

This figure shows the co-authorship network connecting the top 25 collaborators of Mark P. Burgoon. A scholar is included among the top collaborators of Mark P. Burgoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark P. Burgoon. Mark P. Burgoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Xiaoli, et al.. (2010). Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF. Journal of Neuroimmunology. 233(1-2). 192–203. 15 indexed citations
2.
Cameron, Elizabeth, Sade Spencer, Christopher Harp, et al.. (2009). Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. Journal of Neuroimmunology. 213(1-2). 123–130. 39 indexed citations
3.
Burgoon, Mark P., Randall J. Cohrs, Jeffrey L. Bennett, et al.. (2009). Varicella zoster virus is not a disease‐relevant antigen in multiple sclerosis. Annals of Neurology. 65(4). 474–479. 40 indexed citations
4.
Owens, Gregory P., Jeffrey L. Bennett, Hans Lassmann, et al.. (2009). Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Annals of Neurology. 65(6). 639–649. 153 indexed citations
5.
Yu, Xiaoli, Olga Barmina, Mark P. Burgoon, & Don Gilden. (2009). Identification of measles virus epitopes using an ultra-fast method of panning phage-displayed random peptide libraries. Journal of Virological Methods. 156(1-2). 169–173. 10 indexed citations
6.
Bennett, Jeffrey L., Alanna Ritchie, Mark P. Burgoon, et al.. (2008). CSF IgG heavy-chain bias in patients at the time of a clinically isolated syndrome. Journal of Neuroimmunology. 199(1-2). 126–132. 29 indexed citations
7.
Owens, Gregory P., Kimberly M. Winges, Alanna Ritchie, et al.. (2007). VH4 Gene Segments Dominate the Intrathecal Humoral Immune Response in Multiple Sclerosis. The Journal of Immunology. 179(9). 6343–6351. 55 indexed citations
8.
Yu, Xiaoli, Mark P. Burgoon, Andrew Shearer, & Donald H. Gilden. (2007). Characterization of phage peptide interaction with antibody using phage mediated immuno-PCR. Journal of Immunological Methods. 326(1-2). 33–40. 20 indexed citations
9.
10.
Owens, Gregory P., Jeffrey L. Bennett, Donald H. Gilden, & Mark P. Burgoon. (2006). The B cell response in multiple sclerosis. Neurological Research. 28(3). 236–244. 63 indexed citations
11.
Owens, Gregory P., et al.. (2005). Laser capture microdissection and single-cell RT-PCR without RNA purification. Journal of Immunological Methods. 302(1-2). 90–98. 37 indexed citations
12.
Ritchie, Alanna, Donald H. Gilden, R. Anthony Williamson, et al.. (2004). Comparative Analysis of the CD19+ and CD138+ Cell Antibody Repertoires in the Cerebrospinal Fluid of Patients with Multiple Sclerosis. The Journal of Immunology. 173(1). 649–656. 70 indexed citations
13.
Owens, Gregory P., Alanna Ritchie, Mark P. Burgoon, et al.. (2003). Single-Cell Repertoire Analysis Demonstrates that Clonal Expansion Is a Prominent Feature of the B Cell Response in Multiple Sclerosis Cerebrospinal Fluid. The Journal of Immunology. 171(5). 2725–2733. 174 indexed citations
14.
Burgoon, Mark P., et al.. (2003). Oligoclonal immunoglobulins in cerebrospinal fluid during varicella zoster virus (VZV) vasculopathy are directed against VZV. Annals of Neurology. 54(4). 459–463. 35 indexed citations
15.
16.
Gilden, Donald H., Mark P. Burgoon, Bette K. Kleinschmidt‐DeMasters, et al.. (2001). Molecular Immunologic Strategies to Identify Antigens and B-Cell Responses Unique to Multiple Sclerosis. Archives of Neurology. 58(1). 43–8. 13 indexed citations
17.
18.
19.
Owens, Gregory P., et al.. (1998). Restricted use of VH4 Germline segments in an acute multiple sclerosis brain. Annals of Neurology. 43(2). 236–243. 144 indexed citations
20.
Owens, Gregory P., et al.. (1997). Extraction and purification of active IgG from SSPE and MS brain. Journal of Virological Methods. 68(2). 119–125. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alanna Ritchie Breakdown of academic impact, for papers by H P Ekre Breakdown of academic impact, for papers by Ying C. Q. Zang Breakdown of academic impact, for papers by Chi Chao Chan Breakdown of academic impact, for papers by Claire H. Sweenie Breakdown of academic impact, for papers by Purnima Sundar Breakdown of academic impact, for papers by M Flerlage Breakdown of academic impact, for papers by Y. K. Chou Breakdown of academic impact, for papers by William Siders Breakdown of academic impact, for papers by Rachael Bashford-Rogers
Rankless by CCL
2026